Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05903092
Title MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer (MOZART)
Acronym MOZART
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hirva Mamdani
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.